AOSpine outcome instruments

Disease-specific outcome tools developed and validated by AOSpine

SOSGOQ2.0 for spine oncology patients

AOSpine Knowledge Forum (KF) Tumor recently validated the first spine oncology-specific patient-reported outcome (PRO) tool, the SOSGOQ2.0. 

The PRO allows you to define whether your patients are improving and will serve to improve their quality of life.

Use the SOSGOQ2.0 in combination with a generic instrument.

The study was published in Cancer, April 15, 2018 Vol. 124(8).

The SOSGOQ2.0 research has been awarded:

  • AOSpine Europe's Young Researcher Award, first place, 2018
  • Best Paper Award, 30th European Musculo-Skeletal Oncology Society meeting (EMSOS), 2017



Anne Versteeg
“Importantly, with the SOSGOQ2.0, we could see differences between patients within the population—seriously disabled patients have lower scores compared to those who are doing better—which is what you want.”

Anne Versteeg, lead author

You might also be interested in


Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.